Laguna Blends Inc.'s (LAG.C) exclusive Cannaceuticals cannabidiol skin care licence has been expanded into Japan, Germany, Thailand and South Korea. ISO International LLC ("ISO"), (the supplier for Cannaceuticals) has granted to Laguna the exclusive, transferable, perpetual, irrevocable, royalty-free right and license to distribute the products in the licensed territories, either under the product trademarks or on a white label basis. In addition, Laguna may sub-license these rights and licenses to any third party without the consent of the supplier.
The expansion of the additional licensed territories in Asia and Europe fast tracks Laguna to be a worldwide player in the distribution of Cannabidiol ("CBD") skin care products. The global skin care industry is currently estimated at $121 billion US and the market demand for CBD products is growing at an expediential rate. Laguna is positioning itself in the multibillion dollar skin care market. Laguna's market strategy is online sales, joint ventures and through licensing opportunities.
Laguna previously announced that it had received an exclusive license for the CannaCeutical product line in the USA and Canada, see press release dated August 09, 2016.
Laguna launched sales of the Cannaceutical products in the USA on September 13th of 2016.
Stuart Gray, CEO of Laguna Blends said, "By acquiring the additional exclusive licenses in Japan, Germany, Thailand and South Korea we can capitalize on the global demand for high quality skin care products." Stuart Gray went on to say, "We feel there is nothing like the Cannaceutical product line anywhere in the world today and in a recent clinical study evaluating the efficacy of Canna's CBD facial serum, test subjects using the product noted a 100% overall improvement to the appearance of skin in just two weeks."
Sherrie Berry, the formulator of Cannaceuticals by Laguna Blends explains in a 19-minute interview why the products work so well and why they're unique in the skin care industry.
What is Cannabidiol Cannabidiol ("CBD") is a non-psychoactive cannabinoid found in abundance in the hemp plant. Hemp genetics are naturally rich in CBD as well as other non-psychoactive cannabinoids and phytochemicals. CBD, and all the other cannabinoids in the cannabis plant, were patented by the United States Government in 2003 as neuroprotectants and antioxidants.